TKIs for Advanced HCC in the Second Line and Beyond
In this podcast episode, experts Josep M. Llovet, MD, PhD, and Univ. Prof. Markus Peck-Radosavljevic, MD, MBA, discuss the role of tyrosine kinase inhibitors in treating patients with advanced HCC in the second line and beyond.
You May Also Like
Social Confidence | Affirmations for Charisma & Connection
Peak State Labs
ADHD, But Make It Spiritual
Peak State Labs
Sadhguru Français
Sadhguru Français
リセマム 最新教育情報
株式会社イード
Make Your Damn Bed
Julie Merica
Learn French with daily podcasts
Choses à Savoir
Choses à Savoir - Culture générale
Choses à Savoir
Daily Boost - Motivation and Coaching
Scott Smith
Kabbalah Media | mp3 #kab_ger
Bnei Baruch Kabbalah Education and Research Institute, Бней Барух – Ассоциация "Каббала Ла-Ам"
Kabbalah: Lezioni del giorno | mp3 #kab_ita
Bnei Baruch Kabbalah Education and Research Institute, Бней Барух – Ассоциация "Каббала Ла-Ам"
Social Confidence | Affirmations for Charisma & Connection
Peak State Labs
ADHD, But Make It Spiritual
Peak State Labs
Sadhguru Français
Sadhguru Français
リセマム 最新教育情報
株式会社イード
Make Your Damn Bed
Julie Merica
Learn French with daily podcasts
Choses à Savoir
Choses à Savoir - Culture générale
Choses à Savoir
Daily Boost - Motivation and Coaching
Scott Smith
Kabbalah Media | mp3 #kab_ger
Bnei Baruch Kabbalah Education and Research Institute, Бней Барух – Ассоциация "Каббала Ла-Ам"
Kabbalah: Lezioni del giorno | mp3 #kab_ita
Bnei Baruch Kabbalah Education and Research Institute, Бней Барух – Ассоциация "Каббала Ла-Ам"
Community discussion